Synta Pharmaceuticals Corp (SNTA.OQ) Analyst Research| Reuters.com
Edition:
United States

Synta Pharmaceuticals Corp (SNTA.OQ)

SNTA.OQ on NASDAQ Stock Exchange Capital Market

0.28USD
28 Jun 2016
Change (% chg)

-- (--)
Prev Close
$0.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
264,706
52-wk High
$2.37
52-wk Low
$0.15

Reports per page
Select Report Title Date Provider Pgs Price
ValuEngine Rating and Forecast Report for SNTA 25 Jun 2016 ValuEngine, Inc. 11 25.00
Synta Pharmaceuticals 25 Jun 2016 S&P Capital IQ Quantitative Report 10 115.00
SYNTA PHARMACEUTICALS INC (SNTA=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS 24 Jun 2016 Pechala's Reports 2 25.00
Synta Pharmaceuticals Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 24 Jun 2016 Reuters Investment Profile 12 20.00
Value Graph: SYNTA PHARMACEUT -- SNTA 23 Jun 2016 Ford Investor Services, Inc. 1 12.00
Thomson Reuters Stock Report - Synta Pharmaceuticals Corp (SNTA-O) 16 Jun 2016 Thomson Reuters Stock Report 12 25.00
Thomson Reuters Stock Report - Synta Pharmaceuticals Corp (SNTA-O) 10 May 2016 Thomson Reuters Stock Report 12 25.00
Synta Pharmaceuticals Corp. (SNTA) - Financial and Strategic SWOT Analysis Review 10 May 2016 GlobalData 67 300.00
SNTA.OQ - Event Transcript of Synta Pharmaceuticals Corp conference call, Apr. 14, 2016 / 8:30AM ET 14 Apr 2016 Thomson Reuters StreetEvents 8 75.00
Thomson Reuters Stock Report - Synta Pharmaceuticals Corp (SNTA-O) 3 Apr 2016 Thomson Reuters Stock Report 12 25.00
 
Name Age Since Current Position

Keith Gollust

69 2014 Chairman of the Board

Chen Schor

42 2015 President, Chief Executive Officer, Director

Marc Schneebaum

60 2014 Chief Financial Officer, Senior Vice President

Wendy Rieder

47 2015 Senior Vice President, General Counsel

Scott Morenstein

39 2015 Director